Compare FLNT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNT | NSPR |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4M | 81.8M |
| IPO Year | N/A | N/A |
| Metric | FLNT | NSPR |
|---|---|---|
| Price | $2.96 | $1.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 78.9K | 41.8K |
| Earning Date | 02-27-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $212,352,000.00 | $7,779,000.00 |
| Revenue This Year | N/A | $22.76 |
| Revenue Next Year | $11.71 | $75.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.04 |
| 52 Week Low | $1.50 | $1.51 |
| 52 Week High | $3.56 | $3.80 |
| Indicator | FLNT | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 60.74 | 34.22 |
| Support Level | $2.81 | $1.51 |
| Resistance Level | $3.56 | $1.66 |
| Average True Range (ATR) | 0.27 | 0.14 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 60.29 | 10.94 |
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.